UNSPSC 51262002: Carvedilol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C24H26N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0K47UL67F2, chemically known as 2-propanol, 1-(9h-carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)-, (+-)- but generally known as carvedilol, which bears US NIH Compound Identifier 2585. Carvedilol most often comes in base and phosphate forms. European Medicines Agency schedules Carvedilol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06153MIG.

UNSPSC 51262002 Carvedilol is a Commodity code for a specific pharmaceutical product, but the recent state and local opportunities posted under this code do not reflect procurement of carvedilol itself. Instead, they show state and local health agencies soliciting naloxone delivery systems and pharmacy benefit management services — purchases unrelated to the narrow product scope the code nominates. Seminole County, Florida posted an IFB on June 30, 2026, for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, and the Texas Health and Human Services Commission issued an RFI on April 3, 2026, to explore direct-to-manufacturer prescription fulfillment programs for state employee health plans. Neither solicitation aligns with carvedilol procurement, suggesting the code sees little relevant recent activity or receives misclassified opportunities in the state and local system.

The geographic activity touches Florida and Texas through the two opportunities named, but the mismatch between the code's pharmaceutical-product scope and the actual health-services work being solicited indicates that carvedilol is not a meaningful procurement driver in current state and local contracting. Business development professionals evaluating this code should verify whether opportunities are correctly tagged and whether carvedilol demand exists in state pharmacy, corrections, or health-department purchasing outside the recent sample shown here.